Streetbeat News

Regulatory

FANH

WDH

Waterdrop Inc. (NYSE:WDH) reported a slight revenue decline in Q2 but a significant profit increase due to cost control. The company reaffirmed its annual growth forecast and announced a special dividend. Challenges include regulatory changes affecting insurance brokers and a decline in revenue from its clinical trial business. Waterdrop's shares rose 5.7% following the announcement.

Portfolio Pulse from The Bamboo Works

September 09, 2024 | 1:25 pm

MULN

Mullen's subsidiary, Bollinger Motors, has received certification from the California Air Resources Board, enabling its customers to qualify for additional state incentives.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:16 pm

TTOO

T2 Biosystems is advancing its product development pipeline, with plans to file a 510(k) application for the T2Resistance® Panel with the FDA in Q4 2024. The company is also awaiting FDA clearance for the T2Candida® Panel's expanded use and plans to submit a 510(k) for the T2Bacteria® Panel. T2 Biosystems intends to launch the T2Lyme™ Panel as an LDT and is seeking non-dilutive funding for a Candida auris diagnostic test.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:10 pm

ABBV

AbbVie will present new data from its Antibody-Drug Conjugate (ADC) platform at the ESMO Congress 2024. The presentation will highlight mirvetuximab soravtansine for ovarian cancer, and telisotuzumab vedotin and adizutecan for non-small cell lung and gastroesophageal cancers.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:08 pm

RZLT

Rezolute shares increased after the FDA lifted partial clinical holds on their drug RZ358.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:02 pm

CLPS

CLPS has regained compliance with Nasdaq's minimum bid price requirement by maintaining a stock price of at least $1.00 per share for 10 consecutive days.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:51 pm

IDAI

Trust Stamp (NASDAQ:IDAI) has been granted a new patent for a Personal Identifiable Information Encoder, which aims to enhance data protection and privacy by allowing the utility of PII without storing sensitive data.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:42 pm

FEMY

Femasys has received U.S. FDA clearance to market its product, FemChec. This regulatory approval is a significant milestone for the company, potentially impacting its market presence and financial performance.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:38 pm

IBRX

ImmunityBio, Inc. (IBRX) presented promising Phase 2 data at the World Conference on Lung Cancer, showing prolonged survival in NSCLC patients using ANKTIVA with checkpoint inhibitors. The data supports Phase 3 trials and potential global launch.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:36 pm

SOAR

Volato has announced that the New York Stock Exchange (NYSE) has accepted its compliance plan. This development is crucial for Volato as it works to meet the NYSE's listing standards.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:31 pm